Cyclacel Pharma (CYCC) Reports Q2 Loss of $0.10

Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.10), versus ($0.22) reported last year. Revenue for the quarter came in at $356 thousand, versus $296 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Delta Air shares slip despite strong outlook, Melius says
• Financial Select Sector SPDR ETF (XLF) spreader of 20K contracts of July 31 weekly 57 and 59 calls into bank earnings season